The stock's fall snapped a four-day winning streak.

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Fintel reports that on October 8, 2024, Oppenheimer initiated coverage of Abbott Laboratories (NYSE:ABT) with a Outperform ...

Abbott Laboratories (ABT – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst ...

Abbott Laboratories's ABT short percent of float has risen 4.05% since its last report. The company recently reported that it ...

The economic impact of AI is projected to be substantial, particularly in regions like China and North America, which are ...

CNBC’s Jim Cramer explains why he is keeping an eye on shares of Abbott Labs.

Speaking of which, we noticed some great changes in Abbott Laboratories' (NYSE:ABT) returns on capital, so let's have a look. Just to clarify if you're unsure, ROCE is a metric for evaluating how ...

Abbott (ABT) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term. Shares of ...

Compared to the aggregate P/E ratio of the 273.66 in the Health Care Equipment & Supplies industry, Abbott Laboratories Inc. has a lower P/E ratio of 35.76. Shareholders might be inclined to think ...

Abbott Laboratories reported it achieved new major milestones to support the company's growing suite of pulsed field ablation (PFA) solutions in electrophysiology: early completion of enrollment in ...

Abbott Laboratories closed $9.00 below its 52-week high ($121.64), which the company reached on March 8th.